Actualités TenX Keane Acquisition - TENK | Actions NASDAQ

Votre Hub pour des idées et discussions en direct en temps réel

Premium

TenX Keane Acquisition Addresses Trading Halt, Continues Towards Closing of Business Combination, and Provides Market Update

TenX Keane shareholders voted to approve the previously announced merger with Citius Oncology at an...

TenX Keane Acquisition Shareholders Approve Previously Announced Merger to Form Citius Oncology, Inc., a Publicly Listed Subsidiary of Citius Pharmaceuticals

TenX Keane shareholders voted to approve the previously announced merger with Citius Oncology at an...

Citius Pharmaceuticals Details Near-Term Milestones for Late-Stage Candidates

Citius Pharmaceuticals Details Near-Term Milestones for Late-Stage Candidates PR Newswire CRANFORD, N.J., July...

TenX Keane Acquisition Announces Contribution to Trust Account in Connection with Extension Amendment Proposal

New York, NY, Jan. 10, 2024 (GLOBE NEWSWIRE) -- TenX Keane Acquisition (Nasdaq: TENKU, TENK, TENKR) (the...

Citius Pharmaceuticals Executes Definitive Agreement to Merge Wholly Owned Subsidiary with TenX Keane Acquisition to Form Publicly Listed Citius Oncology, Inc.

Citius Pharmaceuticals, Inc. to receive $675 million in equity of Citius Oncology, Inc. and retain...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

TenX Keane Acquisition (TENK)

Votre Hub pour des idées et discussions en direct en temps réel

TENK Actualités

TenX Keane Acquisition Addresses Trading Halt, Continues Towards Closing of Business Combination, and Provides Market Update

TenX Keane Acquisition Shareholders Approve Previously Announced Merger to Form Citius Oncology, Inc., a Publicly Listed Subsidiary of Citius Pharmaceuticals

Citius Pharmaceuticals Details Near-Term Milestones for Late-Stage Candidates

TenX Keane Acquisition Announces Contribution to Trust Account in Connection with Extension Amendment Proposal

Citius Pharmaceuticals Executes Definitive Agreement to Merge Wholly Owned Subsidiary with TenX Keane Acquisition to Form Publicly Listed Citius Oncology, Inc.

TenX Keane Acquisition Announces Extension of the Deadline for an Initial Business Combination

TenX Keane Acquisition Announces Extension of the Deadline for an Initial Business Combination

Quarterly Report (10-q)

Notification That Annual Report Will Be Submitted Late (nt 10-k)

Amended Statement of Ownership (sc 13g/a)

Statement of Ownership (sc 13g)

Amended Statement of Ownership (sc 13g/a)

Amended Statement of Ownership (sc 13g/a)

TenX Keane Acquisition Announces the Separate Trading of its Ordinary Shares and Rights Commencing on December 8, 2022

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

TenX Keane Acquisition (TENK) Actualités

TenX Keane Acquisition (TENK)

Votre Hub pour des idées et discussions en direct en temps réel

TENK Actualités

TenX Keane Acquisition Addresses Trading Halt, Continues Towards Closing of Business Combination, and Provides Market Update

TenX Keane Acquisition Shareholders Approve Previously Announced Merger to Form Citius Oncology, Inc., a Publicly Listed Subsidiary of Citius Pharmaceuticals

Citius Pharmaceuticals Details Near-Term Milestones for Late-Stage Candidates

TenX Keane Acquisition Announces Contribution to Trust Account in Connection with Extension Amendment Proposal

Citius Pharmaceuticals Executes Definitive Agreement to Merge Wholly Owned Subsidiary with TenX Keane Acquisition to Form Publicly Listed Citius Oncology, Inc.

TenX Keane Acquisition Announces Extension of the Deadline for an Initial Business Combination

TenX Keane Acquisition Announces Extension of the Deadline for an Initial Business Combination

Quarterly Report (10-q)

Notification That Annual Report Will Be Submitted Late (nt 10-k)

Amended Statement of Ownership (sc 13g/a)

Statement of Ownership (sc 13g)

Amended Statement of Ownership (sc 13g/a)

Amended Statement of Ownership (sc 13g/a)

TenX Keane Acquisition Announces the Separate Trading of its Ordinary Shares and Rights Commencing on December 8, 2022

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application